
    
      Male or female participants between 18 - 65 years of age with moderate to severe CD for whom
      the treating physician had recently initiated an anti-TNF treatment were included in this
      study. Anti-TNF treatments were administered according to the treating physician's decision
      and applicable product label in Turkey. No interventions were made to the treatment and the
      participant discontinuance or to the follow-up decisions of the treating physician. Enrolled
      participants were observed for one year.
    
  